Lymphedema: Pathophysiology and clinical manifestations

Journal of the American Academy of Dermatology

Volumn 77, Issue 6, 2017, Pages 1009-1020

  Grada, Ayman A ^a   Phillips, Tania J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lymphedema; pathophysiology; primary; secondary; skin

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACICLOVIR; ALPHA2A INTERFERON; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ESTROGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDRALAZINE; INTERLEUKIN 2; INTERLEUKIN 4; METHYLDOPA; MINOXIDIL; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOTHIAZINE; PROGESTERONE; TRAZODONE;

ANGIOSARCOMA; ANXIETY; CHRONIC VEIN INSUFFICIENCY; CLINICAL FEATURE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EDEMA; ELEPHANTIASIS; HEALTH; HUMAN; HYPOALBUMINEMIA; LIPEDEMA; LYMPHEDEMA; MORBID OBESITY; MYXEDEMA; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PODOCONIOSIS; PRIORITY JOURNAL; REVIEW; RISK; SKIN INFECTION; SKIN ULCER;

HUMANS; LYMPHEDEMA;

EID: 85033684240     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2017.03.022     Document Type: Review

References (72)

1. Mohrman, D.E., Heller, L.J., Cardiovascular Physiology. 8th ed., 2014, McGraw-Hill, New York.
2. Ganong, W.F., Review of Medical Physiology. 24th ed., 2012, McGraw-Hill Medical, New York.
3. Alitalo, K., The lymphatic vasculature in disease. Nat Med 17 (2011), 1371–1380.
4. Avraham, T., Zampell, J.C., Yan, A., et al. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema. FASEB J 27 (2013), 1114–1126.
5. Rockson, S.G., Rivera, K.K., Estimating the population burden of lymphedema. Ann N Y Acad Sci 1131 (2008), 147–154.
6. Földi, M., Földi, E., Kubik, S., Textbook of Lymphology for Physicians and Lymphedema Therapists. 2003, Urgan & Fischer Verlag, New York.
7. Smeltzer, D.M., Stickler, G.B., Schirger, A., Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics 76 (1985), 206–218.
8. Fitzpatrick, T.B., Wolff, K., Fitzpatrick's Dermatology in General Medicine. 7th ed., 2008, McGraw-Hill Medical, New York.
9. Greene, A.K., Slavin, S.A., Brorson, H., (eds.) Lymphedema: Presentation, Diagnosis, and Treatment, 2015, Springer, Cham, Switzerland.
10. Kurt, H., Arnold, C.A., Payne, J.E., Miller, M.J., Skoracki, R.J., Iwenofu, O.H., Massive localized lymphedema: a clinicopathologic study of 46 patients with an enrichment for multiplicity. Mod Pathol 29 (2016), 75–82.
11. Karaca-Mandic, P., Hirsch, A.T., Rockson, S.G., Ridner, S.H., The cutaneous, net clinical, and health economic benefits of advanced pneumatic compression devices in patients with lymphedema. JAMA Dermatol 151 (2015), 1187–1193.
12. Greene, A.K., Grant, F.D., Slavin, S.A., Lower-extremity lymphedema and elevated body-mass index. N Engl J Med 366 (2012), 2136–2137.
13. Gillespie, S.H., Basic lymphoedema management: treatment and prevention of problems associated with lymphatic filariasis. Int J Infect Dis, 5, 2004, 321.
14. Meneses, K.D., McNees, M.P., Upper extremity lymphedema after treatment for breast cancer: a review of the literature. Ostomy Wound Manage 53 (2007), 16–29.
15. Garfein, E.S., Borud, L.J., Warren, A.G., Slavin, S.A., Learning from a lymphedema clinic: an algorithm for the management of localized swelling. Plast Reconstr Surg 121 (2008), 521–528.
16. Cormier, J.N., Askew, R.L., Mungovan, K.S., Xing, Y., Ross, M.I., Armer, J.M., Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 116 (2010), 5138–5149.
17. Schook, C.C., Mulliken, J.B., Fishman, S.J., Grant, F.D., Zurakowski, D., Greene, A.K., Primary lymphedema: clinical features and management in 138 pediatric patients. Plast Reconstr Surg 127 (2011), 2419–2431.
18. Oremus, M., Walker, K., Dayes, I., Raina, P., Diagnosis and treatment of secondary lymphedema. 2010, Agency for Healthcard Research and Quality, Rockville, MD.
19. Shih, Y.C., Xu, Y., Cormier, J.N., et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27 (2009), 2007–2014.
20. Brayton, K.M., Hirsch, A.T., Patricia, J., Cheville, A., Karaca-Mandic, P., Rockson, S.G., Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs. PLoS One, 9, 2014, e114597.
21. Brouillard, P., Boon, L., Vikkula, M., Genetics of lymphatic anomalies. J Clin Invest 124 (2014), 898–904.
22. Stewart, G., Lymphoedema: pathophysiology and classification. J Cardiovasc Surg 26 (1984), 91–106.
23. Mellor, R.H., Hubert, C.E., Stanton, A.W., et al. Lymphatic dysfunction, not aplasia, underlies Milroy disease. Microcirculation 17 (2010), 281–296.
24. Kerchner, K., Fleischer, A., Yosipovitch, G., Lower extremity lymphedema update: pathophysiology, diagnosis, and treatment guidelines. J Am Acad Dermatol 59 (2008), 324–331.
25. Du Vivier, A., McKee, P.H., Salisbury, J.R., Atlas of Clinical Dermatology. 3rd ed., 2002, Churchill Livingstone, London.
26. Bull, R.H., Gane, J.N., Evans, J.E., Joseph, A.E., Mortimer, P.S., Abnormal lymph drainage in patients with chronic venous leg ulcers. J Am Acad Dermatol 28 (1993), 585–590.
27. Raju, S., Furrh, 4th JB, Neglén P. Diagnosis and treatment of venous lymphedema. J Vasc Surg 55 (2012), 141–149.
28. Schlögel, M.J., Brouillard, P., Boon, L.M., Vikkula, M., Genetic causes of lymphedema. Greene, A.K., Slavin, S.A., Brorson, H., (eds.) Lymphedema: presentation, diagnosis, and treatment, 2015, Springer, Cham, Switzerland, 19–31.
29. World Health Organization website. Lymphatic filariasis. Available from: http://www.who.int/mediacentre/factsheets/fs102/en/. Accessed April 28, 2017.
30. Butler, D.F., Malouf, P.J., Batz, R.C., Stetson, C.L., Acquired lymphedema of the hand due to herpes simplex virus type 2. Arch Dermatol 135 (1999), 1125–1126.
31. Rockson, S.G., Lymphedema. Am J Med 110 (2001), 288–295.
32. Mabey, D., Peeling, R., Lymphogranuloma venereum. Sex Transm Infect 78 (2002), 90–92.
33. Simonian, S.J., Morgan, C.L., Tretbar, L.L., Blondeau, B., Differential diagnosis of lymphedema. Tretbar, L.L., Morgan, C.L., Lee, B.B., Simonian, S.J., Blondeau, B., (eds.) Lymphedema: Diagnosis and Treatment, 2008, Springer-Verlag, London, 12–20.
34. Avraham, T., Yan, A., Zampell, J.C., et al. Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-β1-mediated tissue fibrosis. Am J Physiol Cell Physiol 299 (2010), C589–C605.
35. Cormier, J.N., Askew, R.L., Mungovan, K.S., Xing, Y., Ross, M.I., Armer, J.M., Lymphedema beyond breast cancer. Cancer 116 (2010), 5138–5149.
36. Beesley, V., Janda, M., Eakin, E., Obermair, A., Battistutta, D., Lymphedema after gynecological cancer treatment. Cancer 109 (2007), 2607–2614.
37. Molyneux, D.H., Tropical lymphedemas–control and prevention. N Engl J Med 366 (2012), 1169–1171.
38. Davey, G., Tekola, F., Newport, M.J., Podoconiosis: non-infectious geochemical elephantiasis. Trans R Soc Trop Med Hyg 101 (2007), 1175–1180.
39. Kloos, H., Bedri Kello, A., Addus, A., Podoconiosis (endemic non-filarial elephantiasis) in two resettlement schemes in western Ethiopia. Trop Doct 22 (1992), 109–112.
40. Asch, S., James, W.D., Castelo-Soccio, L., Massive localized lymphedema: an emerging dermatologic complication of obesity. J Am Acad Dermatol, 59(5 suppl), 2008, S109.
41. Mehrara, B.J., Greene, A.K., Lymphedema and obesity: is there a link?. Plast Reconstr Surg, 134, 2014, 154e.
42. Savetsky, I.L., Torrisi, J.S., Cuzzone, D.A., et al. Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema. Am J Physiol Heart Circ Physiol 307 (2014), H165–H172.
43. Farshid, G., Weiss, S.W., Massive localized lymphedema in the morbidly obese: a histologically distinct reactive lesion simulating liposarcoma. Am J Surg Pathol 22 (1998), 1277–1283.
44. Chopra, K., Tadisina, K.K., Brewer, M., Holton, L.H., Banda, A.K., Singh, D.P., Massive localized lymphedema revisited: a quickly rising complication of the obesity epidemic. Ann Plast Surg 74 (2015), 126–132.
45. Fife, C., Massive localized lymphedema, a disease unique to the morbidly obese: a case study. Ostomy Wound Manage 60 (2014), 30–35.
46. Tiwari, A., Cheng, K.S., Button, M., Myint, F., Hamilton, G., Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg 138 (2003), 152–161.
47. Ciocon, J.O., Galindo-Ciocon, D., Galindo, D.J., Raised leg exercises for leg edema in the elderly. Angiology 46 (1995), 19–25.
48. Mortimer, P., Evaluation of lymphatic function: abnormal lymph drainage in venous disease. Int Angiol 14:3 suppl 1 (1995), 32–35.
49. Fonder, M.A., Loveless, J.W., Lazarus, G.S., Lipedema, a frequently unrecognized problem. J Am Acad Dermatol 57:2 suppl (2007), S1–S3.
50. Rudkin, G.H., Miller, T.A., Lipedema: a clinical entity distinct from lymphedema. Plast Reconstr Surg 94 (1994), 841–847.
51. Harwood, C., Bull, R., Evans, J., Mortimer, P., Lymphatic and venous function in lipoedema. Br J Dermatol 134 (1996), 1–6.
52. Kaizu, K., Abe, M., Drug-induced edema. [in Japanese] Nihon Rinsho 63 (2005), 102–106.
53. Toland, H., McCloskey, K., Thornbury, K.D., McHale, N.G., Hollywood, M.A., Ca2+-activated Cl− current in sheep lymphatic smooth muscle. Am J Physiol Cell Physiol 279 (2000), C1327–C1335.
54. Bull, R.H., Coburn, P.R., Mortimer, P.S., Pretibial myxoedema: a manifestation of lymphoedema?. Lancet 341 (1993), 403–404.
55. Parving, H.H., Hansen, J.M., Nielsen, S.L., Rossing, N., Munck, O., Lassen, N.A., Mechanisms of edema formation in myxedema—increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med 301 (1979), 460–465.
56. Damstra, R., Van Steensel, M., Boomsma, J., Nelemans, P., Veraart, J., Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br J Dermatol 158 (2008), 1210–1215.
57. Soo, J., Bicanic, T., Heenan, S., Mortimer, P., Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis. Br J Dermatol 158 (2008), 1350–1353.
58. Sharma, A., Schwartz, R.A., Stewart–Treves syndrome: pathogenesis and management. J Am Acad Dermatol 67 (2012), 1342–1348.
59. Woodward, A.H., Ivins, J.C., Soule, E.H., Lymphangiosarcoma arising in chronic lymphedematous extremities. Cancer 30 (1972), 562–572.
60. Bingham, H.G., Evans, H., Squamous carcinoma of the foot arising in association with longstanding verrucous hyperplasia in a patient with congenital lymphedema. Plast Reconstr Surg, 76, 1985, 172.
61. Ueno, T., Futagami, A., Mitsuishi, T., Niimi, Y., Shimoda, T., Kawana, S., Basal cell carcinoma arising on a chronic lymphedematous leg. J Dermatol 36 (2009), 646–648.
62. Hills, R., Ive, F., Cutaneous secondary follicular centre cell lymphoma in association with lymphoedema praecox. Br J Dermatol 129 (1993), 186–189.
63. Torres-Paoli, D., Sánchez, J.L., Primary cutaneous B-cell lymphoma of the leg in a chronic lymphedematous extremity. Am J Dermatopathol 22 (2000), 257–260.
64. Tatnall, F., Mann, B., Non-Hodgkin's lymphoma of the skin associated with chronic limb lymphoedema. Br J Dermatol 113 (1985), 751–756.
65. Bartal, A.H., Pinsky, C.M., Malignant melanoma appearing in a post-mastectomy lymphedematous arm: a novel association of double primary tumors. J Surg Oncol 30 (1985), 16–18.
66. Sarkany, I., Malignant melanomas in lymphoedematous arm following radical mastectomy for breast carcinoma (an extension of the syndrome of Stewart and Treves). Proc R Soc Med, 65, 1972, 253.
67. Lee, R., Saardi, K.M., Schwartz, R.A., Lymphedema-related angiogenic tumors and other malignancies. Clin Dermatol 32 (2014), 616–620.
68. Antman, K., Chang, Y., Kaposi's sarcoma. N Engl J Med 342 (2000), 1027–1038.
69. Ruocco, V., Schwartz, R.A., Ruocco, E., Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 47 (2002), 124–127.
70. Passik, S.D., McDonald, M.V., Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer 83:12 Suppl American (1998), 2817–2820.
71. Fu, M.R., Ridner, S.H., Hu, S.H., Stewart, B.R., Cormier, J.N., Armer, J.M., Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psychooncology 22 (2013), 1466–1484.
72. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 46 (2013), 1–11.